A Day Up For Solid Biosciences Inc.
Tue, Jan 09, 2024 at 07:34 PM
Solid Biosciences Inc. (SLDB:NASDAQ) jumped higher at $8.05, a gain of 35.3%. On Tue, Jan 09, 2024, SLDB:NASDAQ hit a New 2-Week High of $8.05. The stock got featured on our News Catalysts scanner on Mon, Jan 08, 2024 at 09:01 AM in the 'PRIVATE PLACEMENT' category. From Tue, Dec 26, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
The stock spiked on Mon, Jan 08, 2024 at $9.04 with a volume of 4M+.
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- Sentage Holdings Inc. (SNTG:NASDAQ), 62.91%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 60.96%
- NexImmune Inc. (NEXI:NASDAQ), 55.88%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 48.89%
- Mountain Crest Acquisition Corp. IV (MCAF:NASDAQ), 48.14%
- Galera Therapeutics, Inc. (GRTX:NASDAQ), 41.42%
- Solid Biosciences Inc. (SLDB:NASDAQ), 35.29%
- Cutera, Inc. (CUTR:NASDAQ), 34.65%
- Leddartech Hldgs Inc Com (LDTC:NASDAQ), 34.03%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 32.73%